Telmisartan is a medication used primarily to treat high blood pressure and heart failure. It belongs to a class of drugs called angiotensin receptor blockers that act by preventing the action of a hormone that constricts blood vessels. By blocking this receptor the drug helps blood vessels relax and reduces the workload on the heart. This vasodilatory effect lowers systemic vascular resistance and improves blood flow throughout the body. The primary active ingredient Telmisartan achieves its effect by selectively inhibiting the angiotensin ii type 1 receptor in the kidneys and peripheral tissues. The resulting decrease in vascular tone leads to reduced blood pressure and improved cardiac output.

Telmisartan is an angiotensin receptor blocker that reduces blood pressure by relaxing blood vessels. It works by blocking the action of angiotensin ii at at1 receptors in the vascular smooth muscle. This decreases vasoconstriction and lowers peripheral resistance. The medication is used to treat hypertension and to improve cardiovascular outcomes in certain patients. Its pharmacological effect results from selective antagonism of the angiotensin ii receptor leading to decreased aldosterone release. The drug's mechanism involves modulation of the renin-angiotensin system to achieve sustained antihypertensive activity.

Telmisartan may cause dizziness as a common reaction. It may also cause headaches in some patients. Fatigue and nausea are reported frequently. A persistent dry cough can occur occasionally. Some users experience low blood pressure resulting in lightheadedness. Elevated potassium levels are rare but have been observed.

Telmisartan may cause dizziness or lightheadedness especially after the first doses. Headache is another frequently reported symptom among users. Some people experience mild nausea or stomach discomfort while taking the medication. Fatigue or unusual tiredness can also occur during treatment. A dry cough has been noted in a small number of patients using the drug. Occasionally low blood pressure may lead to fainting if the dose is too high. Elevated blood potassium levels have been observed in rare cases but are not commonly seen.